1. Home
  2. FMBH vs DMRA Comparison

FMBH vs DMRA Comparison

Compare FMBH & DMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Mid Bancshares Inc.

FMBH

First Mid Bancshares Inc.

N/A

Current Price

$50.65

Market Cap

1.3B

Sector

Finance

ML Signal

N/A

DMRA

Damora Therapeutics Inc. Common Stock

N/A

Current Price

$28.34

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FMBH
DMRA
Founded
1865
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
FMBH
DMRA
Price
$50.65
$28.34
Analyst Decision
Hold
Buy
Analyst Count
5
2
Target Price
$43.40
$43.00
AVG Volume (30 Days)
93.3K
313.1K
Earning Date
04-29-2026
05-11-2026
Dividend Yield
2.33%
N/A
EPS Growth
16.06
121.48
EPS
2.10
N/A
Revenue
N/A
N/A
Revenue This Year
$9.30
N/A
Revenue Next Year
$6.66
N/A
P/E Ratio
$24.11
N/A
Revenue Growth
N/A
N/A
52 Week Low
$34.51
$16.50
52 Week High
$53.36
$34.89

Technical Indicators

Market Signals
Indicator
FMBH
DMRA
Relative Strength Index (RSI) 57.39 43.97
Support Level $50.49 $28.16
Resistance Level $53.36 $28.66
Average True Range (ATR) 0.91 1.48
MACD -0.10 -0.40
Stochastic Oscillator 74.84 29.42

Price Performance

Historical Comparison
FMBH
DMRA

About FMBH First Mid Bancshares Inc.

First Mid Bancshares Inc is a United States based financial holding company. Through its wholly-owned subsidiary, First Mid Bank, it is engaged in the business of banking. The company offers trust, farm services, investment services, and retirement planning through its wholly owned subsidiary, it also provides data processing services to affiliates and insurance products and services to customers through its subsidiary. The company's operations cover community banking, wealth management and insurance services. Key revenue is derived from the provision of community banking services.

About DMRA Damora Therapeutics Inc. Common Stock

Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.

Share on Social Networks: